Literature DB >> 23247824

Nicotinic receptors in addiction pathways.

Frances M Leslie1, Celina Y Mojica, Daisy D Reynaga.   

Abstract

Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels that consist of pentameric combinations of α and β subunits. These receptors are widely distributed throughout the brain and are highly expressed in addiction circuitry. The role of nAChRs in regulating neuronal activity and motivated behavior is complex and varies both in and among brain regions. The rich diversity of central nAChRs has hampered the characterization of their structure and function with use of classic pharmacological techniques. However, recent molecular approaches using null mutant mice with specific regional lentiviral re-expression, in combination with neuroanatomical and electrophysiological techniques, have allowed the elucidation of the influence of different nAChR types on neuronal circuit activity and behavior. This review will address the influence of nAChRs on limbic dopamine circuitry and the medial habenula-interpeduncular nucleus complex, which are critical mediators of reinforced behavior. Characterization of the mechanisms underlying regulation of addiction pathways by endogenous cholinergic transmission and by nicotine may lead to the identification of new therapeutic targets for treating tobacco dependence and other addictions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23247824     DOI: 10.1124/mol.112.083659

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  41 in total

Review 1.  Pain and suicidality: insights from reward and addiction neuroscience.

Authors:  Igor Elman; David Borsook; Nora D Volkow
Journal:  Prog Neurobiol       Date:  2013-07-01       Impact factor: 11.685

2.  Medial habenula output circuit mediated by α5 nicotinic receptor-expressing GABAergic neurons in the interpeduncular nucleus.

Authors:  Yun-Wei A Hsu; Lynne Tempest; Lely A Quina; Aguan D Wei; Hongkui Zeng; Eric E Turner
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

3.  Expression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment.

Authors:  Junran Cao; Tanseli Nesil; Shaolin Wang; Sulie L Chang; Ming D Li
Journal:  J Neurovirol       Date:  2016-04-07       Impact factor: 2.643

Review 4.  Behavioral mechanisms underlying nicotine reinforcement.

Authors:  Laura E Rupprecht; Tracy T Smith; Rachel L Schassburger; Deanne M Buffalari; Alan F Sved; Eric C Donny
Journal:  Curr Top Behav Neurosci       Date:  2015

Review 5.  Neuronal Nicotinic Acetylcholine Receptor Structure and Function and Response to Nicotine.

Authors:  John A Dani
Journal:  Int Rev Neurobiol       Date:  2015-08-21       Impact factor: 3.230

6.  Role of the dorsal medial habenula in the regulation of voluntary activity, motor function, hedonic state, and primary reinforcement.

Authors:  Yun-Wei A Hsu; Si D Wang; Shirong Wang; Glenn Morton; Hatim A Zariwala; Horacio O de la Iglesia; Eric E Turner
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

7.  Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference.

Authors:  Gofarana Wilar; Yasuharu Shinoda; Toshikuni Sasaoka; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2019-05-25       Impact factor: 5.590

Review 8.  Progress in nicotinic receptor structural biology.

Authors:  Anant Gharpure; Colleen M Noviello; Ryan E Hibbs
Journal:  Neuropharmacology       Date:  2020-04-07       Impact factor: 5.250

9.  The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.

Authors:  Jirawoot Srisontiyakul; Hanna E Kastman; Elena V Krstew; Piyarat Govitrapong; Andrew J Lawrence
Journal:  Neurochem Res       Date:  2016-08-29       Impact factor: 3.996

Review 10.  Translating the Habenula-From Rodents to Humans.

Authors:  Laura-Joy Boulos; Emmanuel Darcq; Brigitte Lina Kieffer
Journal:  Biol Psychiatry       Date:  2016-06-07       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.